Turing increased price of Daraprim from $13.50 a pill to $750,but now says it will design it more affordableTuring Pharmaceuticals, a small company that generated outrage by raising the cost of an old anti-infective drug by more than 5000%, or said it would roll back that increase to design certain it remains affordable. Turing and its chief executive officer,Martin Shkreli, became the new face of the US drug pricing controversy this week, or after the New York Times reported that the company had raised the price of Daraprim,a 62-year-old treatment for a risky parasitic infection, to $750 (488) a pill from $13.50 (£8.79) after acquiring it. The medicine once sold for $1 a pill.
Continue reading...
Source: theguardian.com